DD
38
-4
HPQ
21
-4
NKE
24
-4
JNPR
41
-2
GS
66
-7
NVDA
57
-4
EQR
31
-5
CCL
57
-8
MO
53
-3
OXY
48
3
ADT
58
-2
IFF
38
-6
UNP
38
-4
DTE
49
-3
WYNN
21
-4
WM
68
-2
V
36
-16
AEE
66
-5
INTU
69
-5
TAP
31
-4
DD
38
-4
HPQ
21
-4
NKE
24
-4
JNPR
41
-2
GS
66
-7
NVDA
57
-4
EQR
31
-5
CCL
57
-8
MO
53
-3
OXY
48
3
ADT
58
-2
IFF
38
-6
UNP
38
-4
DTE
49
-3
WYNN
21
-4
WM
68
-2
V
36
-16
AEE
66
-5
INTU
69
-5
TAP
31
-4
Financhill
Back

Sarepta Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
43

SRPT
Sarepta Therapeutics

Last Price:
$36.16
Seasonality Move:
12.58%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
$56.24
Seasonality Move:
4.69%
Sell
43
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $36.18. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $56.22. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $36.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $56.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.76 Sell
Relative Strength Index (14 RSI): 35.87 Sell
Chaikin Money Flow: -2066768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.36 - 39.74) Sell
Bollinger Bands (100): (43.1 - 103.68) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.03 Sell
Relative Strength Index (14 RSI): 39.22 Sell
Chaikin Money Flow: -1168335 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.63 - 59.31) Sell
Bollinger Bands (100): (58.22 - 68.58) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.98 Sell
20-day SMA: 38.57 Sell
50-day SMA: 46.61 Sell
200-day SMA: 99.02 Sell
8-day EMA: 38.18 Sell
20-day EMA: 39.82 Sell
50-day EMA: 49.81 Sell
200-day EMA: 87.43 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.63 Sell
20-day SMA: 57.62 Sell
50-day SMA: 59.32 Sell
200-day SMA: 66.97 Sell
8-day EMA: 56.9 Sell
20-day EMA: 57.67 Sell
50-day EMA: 59.92 Sell
200-day EMA: 67.22 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.25 per share, an increase this year of $1.01 per share, and an increase next year of $1.09 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):